News & Updates

Show Multimedia Only

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

The combination of chemotherapy and anti-EGFR/BRAF therapy provides optimal survival benefits to patients with advanced BRAF-mutated colorectal cancer (CRC), according to a study.

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

9 hours ago

Rifaximin does not improve survival in severe cirrhosis

12 Dec 2025

Treatment with rifaximin appears to provide no benefits in terms of 12-month survival or incidence of complications of cirrhosis in patients with severe cirrhosis and low ascitic fluid protein levels, a recent study has shown.

Rifaximin does not improve survival in severe cirrhosis

12 Dec 2025

HCPs, patients willing to trade off OCS benefits to avoid side effects

12 Dec 2025 by

Both patients and healthcare professionals prefer treatment for asthma attacks that avoids the side effects of oral corticosteroids (OCS), and both are willing to trade off benefits, according to a study.

HCPs, patients willing to trade off OCS benefits to avoid side effects

12 Dec 2025

Continuous use of TNFi on the rise in pregnant women

11 Dec 2025

A trend toward increased continuous use of tumour necrosis factor inhibitors has been observed throughout gestation, which suggests growing confidence in the safety and effectiveness of this medication during pregnancy, reveals a study.

Continuous use of TNFi on the rise in pregnant women

11 Dec 2025

Antimicrobial use rises following TNFi initiation in PsA patients

10 Dec 2025

A recent study has noted a temporary increase in antimicrobial use following initiation of tumour necrosis factor inhibitor (TNFi) treatment, with no significant risk in serious infections, among patients with psoriatic arthritis (PsA).

Antimicrobial use rises following TNFi initiation in PsA patients

10 Dec 2025

Nirsevimab cuts RSV burden in newborns

10 Dec 2025 by

A retrospective study from Italy shows an association between nirsevimab prophylaxis and a lower risk of respiratory syncytial virus (RSV) hospitalizations and a milder disease course.

Nirsevimab cuts RSV burden in newborns

10 Dec 2025

Is it safe to take NSAIDs when using oral anticoagulants?

09 Dec 2025 by

The use of oral anticoagulants (OACs) with NSAIDs results in clinical outcomes like those of OAC monotherapy, a study has shown.

Is it safe to take NSAIDs when using oral anticoagulants?

09 Dec 2025

Oral corticosteroids confer little to no GDM risk for expectant mothers

05 Dec 2025 by

Exposure to oral corticosteroids during pregnancy is not associated with the risk of gestational diabetes mellitus (GDM), except for a modest increase during an early exposure window, as shown in a study from South Korea.

Oral corticosteroids confer little to no GDM risk for expectant mothers

05 Dec 2025

Relapse higher in HBeAg- patients after cessation of TAF vs TDF, entecavir

04 Dec 2025

Patients who discontinue tenofovir alafenamide (TAF) therapy appear to have a higher hepatitis B virus relapse rate than those who ceased entecavir or tenofovir disoproxil fumarate (TDF) therapy, according to a recent study.

Relapse higher in HBeAg- patients after cessation of TAF vs TDF, entecavir

04 Dec 2025

Does aspirin use worsen IBD severity in pregnant women?

04 Dec 2025

The use of aspirin among pregnant patients with inflammatory bowel disease (IBD) does not appear to increase the risk of disease severity, reports a study. Low-dose aspirin (LDA) has been prescribed to nearly a third of IBD patients during pregnancy.

Does aspirin use worsen IBD severity in pregnant women?

04 Dec 2025

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

Rifaximin does not improve survival in severe cirrhosis

Rifaximin does not improve survival in severe cirrhosis

HCPs, patients willing to trade off OCS benefits to avoid side effects

HCPs, patients willing to trade off OCS benefits to avoid side effects

Continuous use of TNFi on the rise in pregnant women

Continuous use of TNFi on the rise in pregnant women

Antimicrobial use rises following TNFi initiation in PsA patients

Antimicrobial use rises following TNFi initiation in PsA patients

Nirsevimab cuts RSV burden in newborns

Nirsevimab cuts RSV burden in newborns

Is it safe to take NSAIDs when using oral anticoagulants?

Is it safe to take NSAIDs when using oral anticoagulants?

Oral corticosteroids confer little to no GDM risk for expectant mothers

Oral corticosteroids confer little to no GDM risk for expectant mothers

Relapse higher in HBeAg- patients after cessation of TAF vs TDF, entecavir

Relapse higher in HBeAg- patients after cessation of TAF vs TDF, entecavir

Does aspirin use worsen IBD severity in pregnant women?

Does aspirin use worsen IBD severity in pregnant women?